A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
NextCure, Inc.
NextCure, Inc.
Therapeutic Advances in Childhood Leukemia Consortium
Merck Sharp & Dohme LLC
Big Ten Cancer Research Consortium
Therapeutic Advances in Childhood Leukemia Consortium
University of Illinois at Chicago
Amgen
Pfizer
Altor BioScience
Menarini Group
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Nordic Nanovector
Ipsen
Gilead Sciences
Therapeutic Advances in Childhood Leukemia Consortium
H. Lee Moffitt Cancer Center and Research Institute
Eisai Inc.
BeiGene
Daiichi Sankyo
Gilead Sciences
GlaxoSmithKline
Menarini Group
Eli Lilly and Company
Cancer Research UK
Merck Sharp & Dohme LLC
Yale University
Baylor College of Medicine
Daiichi Sankyo
Gilead Sciences
GlaxoSmithKline
Pfizer
Takeda
Children's Mercy Hospital Kansas City
University of California, San Francisco
Therapeutic Advances in Childhood Leukemia Consortium
Halozyme Therapeutics
Eli Lilly and Company
New Mexico Cancer Research Alliance
Bristol-Myers Squibb
Amgen Research (Munich) GmbH